Latest Updates
What attracts capital in aesthetics?
Blossom Innovations founder and CEO Dr. Irina Erenburg recently discussed this critical question with fellow executives and leading capital managers at the 2019 Aesthetics Innovation Summit. Here’s what they see investors looking for in new aesthetics companies.
What attracts capital in aesthetics?
Blossom Innovations founder and CEO Dr. Irina Erenburg recently discussed this critical question with fellow executives and leading capital managers at the 2019 Aesthetics Innovation Summit. Here’s what they see investors looking for in new aesthetics companies.
Latest Science
Nail Fungus: Embarrassing. Ugly. Dangerous.
Nail fungus, or onychomycosis, is a familiar problem that’s often seen as little more than an unsightly and hard to treat cosmetic issue. But for many of the millions of people worldwide who are affected by this under-treated condition, the impact may be far greater — and far more serious.
Latest News
Dermal fillers: Mitigating Risk in a Booming Business
The global market for dermal fillers is growing faster than ever. But as demand continues to increase, so are the serious risks of mis-targeted injections.
Coming soon: Insights from the 2020 JP Morgan Healthcare Conference
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry — and our leaders were there to participate. Check back soon for their insights and takeaways from discussions related to the dynamic dermatology and aesthetics market.
